<h1 align='center'> 21 CFR Part 11 </h1>

This is a regulatory term, mostly relevant if you’re working with **pharmaceuticals, biotech, or any FDA-regulated environment**.

---

## What is 21 CFR Part 11 :

<div style="display:flex; justify-content:center; gap:10px;">
  <img src="/casestudy/img/cfr1.png" width="400">
</div>

**21 CFR Part 11** is part of the **Code of Federal Regulations (CFR)** issued by the **U.S. FDA (Food and Drug Administration)**. Specifically, it deals with **electronic records and electronic signatures**.

* “21” → Title 21 of the CFR, which covers **Food and Drugs**.
* “CFR Part 11” → Section that regulates **electronic records and electronic signatures**.


### Purpose:

It ensures that **electronic records and signatures are trustworthy, reliable, and equivalent to paper records and handwritten signatures**.

Basically, it answers questions like:

* Can we use electronic forms instead of paper? ✅
* How do we verify that an electronic signature is valid? ✅
* How do we prevent unauthorized access or tampering? ✅


### Key Requirements:

1. **Validation:** Systems must be validated to ensure accuracy, reliability, and consistent performance.
2. **Audit Trails:** Every change to an electronic record must be traceable.
3. **Security Controls:** Access must be restricted to authorized users.
4. **Electronic Signatures:** Must be linked to their records, unique to the user, and verified.
5. **Record Retention:** Records must be retrievable and readable for the required retention period.


### Why it matters:

For companies in pharma, biotech, or medical devices:

* Non-compliance = **FDA warning letters, fines, or product hold**.
* Compliance = electronic workflows can replace paper, save time, and improve efficiency.


💡 **Example:**
Imagine a lab uses an electronic LIMS (Laboratory Information Management System) to track test results. Under Part 11:

* The system must record **who entered or modified data**.
* Each signature must be **linked to a user**.
* You **cannot tamper with past records** without an audit trail.

---
<br>



## 21 CFR Part 11 compliance from an IT/DevOps perspective

### 1. Which systems need to comply?

Any system that creates, modifies, stores, or transmits electronic records for FDA-regulated activities falls under Part 11. Examples include:

- LIMS (Laboratory Information Management Systems) → Tracks lab test results.

- ERP systems → Manufacturing records, inventory of raw materials.

- eCTD / Regulatory submission systems → Submitting electronic documentation to the FDA.

- Clinical Trial Systems → Capturing patient data electronically.

- Electronic Batch Record (EBR) systems → Tracks production processes in pharma.

💡 If it replaces a paper record that would normally be signed by hand, it likely needs Part 11 compliance.


### 2. Core IT Requirements for Compliance

#### a) System Validation

System must work as intended.

* **IQ**: Correct installation (OS, DB, infra)
* **OQ**: Functions work as expected
* **PQ**: Works in real-world use

**DevOps**: CI/CD and IaC must match validated configs. Any change = revalidation.


#### b) Audit Trails

All **create / modify / delete** actions must be logged.

* User ID
* Timestamp
* Action
* Reason (if required)

**DevOps**: Logs must be secure, tamper-proof, and retained.


#### c) User Access Controls

Only authorized users can perform actions.

* Role-based access (RBAC)
* MFA
* Remove inactive users

**DevOps**: Enforce IAM + app-level RBAC.


#### d) Electronic Signatures

Legally binding digital signatures.

* Unique to user
* Linked to record
* Cannot be reused or separated


#### e) Data Integrity

Data must be accurate and untampered.

* Immutable storage
* Hash/checksum validation
* Backups


#### f) Record Retention & Retrieval

Records must be readable for entire retention period.

* Search
* Retrieve
* Export (FDA-acceptable formats)

**DevOps**: Long-term compliant storage (e.g., S3 + versioning).

---
<br>



## Practical example (DevOps perspective)

Imagine a company uses a cloud-based LIMS on AWS:

1. Deployment → Automated Terraform scripts provision EC2 + RDS.

2. Validation → Each environment is tested and documented before going live.

3. Access control → IAM roles restrict who can access production databases.

4. Audit trail → Every record change in RDS is logged to CloudTrail and immutable S3.

5. Electronic signatures → A QA user signs off on test results via a PKI-based signature stored in the database.

6. Backup & retention → Automated snapshots with retention policies and versioning.

- **Result:** FDA auditors can verify the system, trace changes, and confirm the authenticity of electronic records. ✅


> Every change, every deployment, and every user action needs to be controlled and traceable.




---
<br>


#  Case Study: 21 CFR Part 11 + SSO

**Why Organizations Use SSO with Part 11**

**Short answer:**
Because **manual user management + passwords = compliance nightmare**.

read the entire casestudy for detailed explanation:

[Case Study: 21 CFR Part 11 + SSO](/casestudy/cfrSSO.md)


